You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK)預期中期收益將增加逾5%
格隆匯 08-12 20:20

格隆匯8月12日丨 維亞生物(01873.HK)公吿,集團預期相較去年同期,截至2022年6月30日止6個月,收益將增加逾5%,其中CRO業務收益將增加逾25%,CDMO業務收益將基本保持持平;集團預期於期間錄得淨虧損不超過人民幣1億元,而截至2021年6月30日止6個月則呈報淨溢利人民幣9580萬元。

根據現時可獲得資料,董事會認為,錄得淨虧損乃主要由於以下因素所致:(i)中國COVID-19疫情的反覆,使得本期間集團向客户交付產品和服務受到限制;(ii)市場波動導致集團於孵化投資企業的股權的公平值發生不利變動;(iii)外匯匯率的波動導致集團於期間錄得匯兑損失。

此外,預期截至2022年6月30日止6個月,集團的經調整淨利潤約為人民幣8000萬元,較集團截至2021年6月30日止6個月的經調整淨利潤有所下降。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account